Observatory · observe first
AbbVie
ABBV · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.
Historical time machine
Historical observation
20182026
Universe weight
0.580%
12M weight contribution
-0.312 pp
3M weight contribution
-0.103 pp
12M price return
-17.8%
Share of matched S&P 500 members
Monthly observations through Jun 2019
Company price index
A separate dimension from market allocation
Historical observations
Most recent 24 observations at or before the selected month
| Month | Market cap | Universe weight | 12M weight change | 12M return | Above 6M weight average |
|---|---|---|---|---|---|
| Jun 2019 | $107.5bn | 0.580% | -0.312 pp | -17.8% | No |
| May 2019 | $113.4bn | 0.660% | -0.292 pp | -18.8% | Yes |
| Apr 2019 | $117.1bn | 0.652% | -0.290 pp | -13.9% | Yes |
| Mar 2019 | $118.9bn | 0.683% | -0.239 pp | -11.1% | Yes |
| Feb 2019 | $116.9bn | 0.678% | -0.425 pp | -28.6% | Yes |
| Jan 2019 | $120.8bn | 0.398% | -0.624 pp | -25.3% | No |
| Dec 2018 | $138.7bn | 0.496% | -0.526 pp | -15.3% | No |
| Nov 2018 | $141.8bn | 0.471% | -0.551 pp | -13.3% | No |
| Oct 2018 | $117.9bn | 0.400% | -0.622 pp | -28.4% | No |
| Sep 2018 | $143.2bn | 0.456% | -0.566 pp | -14.0% | No |
| Aug 2018 | $145.3bn | 0.469% | -0.553 pp | -12.7% | No |
| Jul 2018 | $146.4bn | 0.854% | -0.168 pp | -16.1% | No |
| Jun 2018 | $147.0bn | 0.892% | -0.130 pp | -16.6% | No |
| May 2018 | $157.0bn | 0.953% | -0.069 pp | -10.9% | No |
| Apr 2018 | $153.3bn | 0.942% | -0.080 pp | -13.1% | No |
| Mar 2018 | $150.3bn | 0.922% | -0.100 pp | -15.7% | No |
| Feb 2018 | $183.9bn | 1.102% | +0.080 pp | +3.2% | Yes |
| Jan 2018 | $179.2bn | 1.022% | +0.000 pp | +0.0% | No |
Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.